AnodyneWiki

Metamizole

Metamizole
Metamizole
Salts
[]
Sodium metamizole
Sodium metamizole
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass311.36 g/mol [1]
Predicted LogP0 [1]
Structural Identifiers
[]
Molecular formulaC13H17N3O4S
IUPAC name[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-methylamino]methanesulfonic acid
SMILESCC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)O
InChIInChI=1S/C13H17N3O4S/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3,(H,18,19,20)
InChIKeyLVWZTYCIRDMTEY-UHFFFAOYSA-N
CAS number50567-35-6
UNII934T64RMNJ
PubChem CID3111
Pharmacokinetics[]
Elimination half-life14 minutes (parent compound; IV route); metabolites: 2–4 hour
Duration of action4–6 hours
MetabolismLiver
ExcretionUrine (96%, IV; 85%, oral), faeces (4%, IV).
Routes of administrationBy mouth, intramuscular, intravenous, rectal

Metamizole (also known as Metamizol, Methamizole, Novamine sulfone, Methamizole-, (antipyrinylmethylamino)methanesulfonic acid, Methanesulfonic acid, (antipyrinylmethylamino)-, N-Methyl-N-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)aminomethanesulfosaeure, Dolemicin, 256-627-7 or Metamizolum) is a analgesic, antipyretics and cyp3a4 inducer substance of the aniline class.

Chemistry

Salts []

Metamizole is typically found in the form of its sodium salt.

 []

Metamizole is achiral.

Metamizole matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

The mechanism of action of metamizole is not fully understood. Its active metabolites, 4-methyl-amino-antipyrine (MAA) and 4-amino-antipyrine (AA), inhibit prostaglandin E2 (PGE<sub>2</sub>)-induced hyperalgesia. It has been suggested that the anti-hyperalgesic effect of MAA is mediated by guanosine 3',5'-cyclic monophosphate (cGMP) activation and ATP-sensitive potassium channel opening, while the effects of AA are associated with the activation of cannabinoid receptor type 1 (CB1). Metamizole is classified in some sources as a weak non-steroidal anti-inflammatory drug (NSAID); however, evidence suggests that its analgesic effects do not depend on its anti-inflammatory properties. Although the inhibition of cyclooxygenase (COX) 2 may play a role in the central nervous system effects of metamizole, reports suggest that metamizole inhibits COX-3 with a higher affinity compared to COX-1 or COX-2. [1]

Subjective effects []

0xea / Metamizole []
Routes:
  • Oral
Notes:
  • effects not notable
alina / Metamizole []
Routes:
  • Oral (250 - 500mg)
  • Intravenous (1000mg)
emily / Metamizole []
Routes:
  • Oral (500mg)
Pilz / Metamizole []
Routes:
  • Oral (500mg)
Forms:
  • Sodium Monohydrate
Source:
  • Polish Pharmacy: Pyralgina
Indication:
  • moderate pain
Effects:Notes:
  • Helped with pain caused by
  • Might help with stress induced muscle twitching

 []

  • Australia: Metamizole is a Withdrawn.
  • Brazil: Metamizole is a OTC.
  • Canada: Metamizole is a Veterinary only.[3]
  • Germany: Metamizole is Prescription only.[4]
  • New Zealand: Metamizole is Prescription only.[5][6]
  • United Kingdom: Metamizole is a Withdrawn.
  • United States: Metamizole is a Veterinary only (horses).[7]
  • European Union: Metamizole is Legally available.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 3111, Metamizole. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3111
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Metamizole. UNII: 934T64RMNJ. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/934T64RMNJ
  3. Notice of Amendment: Addition of Metamizole (Dipyrone) to the Prescription Drug List (PDL). Government of Canada. 2022-07-18. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-metamizole.html
  4. Risikoinformationen - Metamizol (Novalgin, Berlosin, Novaminsulfon, etc.): BfArM weist auf richtige Indikationsstellung und Beachtung von Vorsichtsmaßnahmen und Warnhinweisen hin. Bundesinstitut für Arzneimittel und Medizinprodukte (Federal Institute for Pharmaceuticals and Medical Products). 2009-05-28. https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RI/2009/RI-metamizol.html
  5. Recent NZ Gazette Notices Relating to Classification. medsafe.govt.nz. 2020-03-06. https://www.medsafe.govt.nz/profs/class/recent.asp
  6. Minutes of the 63rd meeting of the Medicines Classification Committee - 10 Oct 2019. medsafe.govt.nz. 2019-12-04. https://www.medsafe.govt.nz/profs/class/Minutes/2016-2020/mccMin10Oct2019.htm
  7. Zimeta (dipyrone injection) - Veterinarians. FDA. November 26, 2019. https://www.fda.gov/animal-veterinary/product-safety-information/zimeta-dipyrone-injection-veterinarians

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 10:24:51
drugspromissing (no DrugsPRO reagent data)2026-11-20 10:24:47
erowidmissing (no Erowid substance of that name)2026-11-20 10:24:47
gsrsok2026-11-20 10:24:48
hmdbmissing (hmdb.ca refused automated access to HMDB0254502)2026-11-20 10:24:47
keggok2026-11-20 10:24:48
pubchemok2026-11-20 10:24:47
redditmissing (no r/tripreports posts mention it)2026-11-20 10:24:47
sidermissing (not in SIDER)2026-11-20 10:24:47
structureok2026-11-20 10:24:47
wikipediaok2026-11-20 10:24:47